Extended-release oral capsule of carbidopa–levodopa in Parkinson disease

Jason Margolesky(University of Miami), Carlos Singer(University of Miami Health System)

Therapeutic Advances in Neurological Disorders

October 30, 2017

10.1177/1756285617737728

Cited by 29

Related Papers

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

|JAMA|2016|397

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

|Sleep Medicine|2013|391

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

|Sleep Medicine|2013|238

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

|Neurology|2016|137

Genotype–Phenotype Relations in Primary Familial Brain Calcification: Systematic <scp>MDSGene</scp> Review

|Movement Disorders|2021|93